These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35877565)

  • 1. ICIs-Related Cardiotoxicity in Different Types of Cancer.
    Dong M; Yu T; Zhang Z; Zhang J; Wang R; Tse G; Liu T; Zhong L
    J Cardiovasc Dev Dis; 2022 Jun; 9(7):. PubMed ID: 35877565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Cardiotoxicity of Immune Checkpoint Inhibitors.
    Nardi Agmon I; Itzhaki Ben Zadok O; Kornowski R
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity in cancer immune-checkpoint therapy: Mechanisms, clinical evidence, and management strategies.
    Sun JY; Qu Q; Lou YX; Hua Y; Sun GZ; Sun W; Kong XQ
    Int J Cardiol; 2021 Dec; 344():170-178. PubMed ID: 34563597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology.
    He Y; Yu H; Dai S; He M; Ma L; Xu Z; Luo F; Wang L
    Genes Dis; 2024 Mar; 11(2):807-818. PubMed ID: 37692505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitors - the revolutionary cancer immunotherapy comes with a cardiotoxic price.
    Achim A; Liblik K; Gevaert S
    Trends Cardiovasc Med; 2024 Feb; 34(2):71-77. PubMed ID: 36152788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do.
    Zito C; Manganaro R; Ciappina G; Spagnolo CC; Racanelli V; Santarpia M; Silvestris N; Carerj S
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity.
    Zarifa A; Lopez-Mattei J; Palaskas N; Iliescu C; Durand JB; Kim PY
    Adv Exp Med Biol; 2020; 1244():277-285. PubMed ID: 32301022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors.
    Esposito R; Fedele T; Orefice S; Cuomo V; Prastaro M; Canonico ME; Ilardi F; De Stefano F; Fiorillo L; Santoro C; Esposito G
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34067474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Call for attention to the scientific issues in cardiovascular adverse effects associated with immune checkpoint inhibitors].
    Zhang ZR
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(42):3328-3331. PubMed ID: 37963733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of immune checkpoint inhibitors: An updated review.
    Behravesh S; Shomali N; Danbaran GR; Aslani S; Hemmatzadeh M; Hosseinzadeh R; Gowhari-Shabgah A; Mohammadi H
    Biotechnol Appl Biochem; 2022 Feb; 69(1):61-69. PubMed ID: 33289168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing cardiotoxicity associated with immune checkpoint inhibitors.
    Upadhrasta S; Elias H; Patel K; Zheng L
    Chronic Dis Transl Med; 2019 Mar; 5(1):6-14. PubMed ID: 30993259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity.
    Zarifa A; Lopez-Mattei J; Palaskas NL; Iliescu C; Durand JB; Kim PY
    Adv Exp Med Biol; 2021; 1342():377-387. PubMed ID: 34972975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitors Related to Cardiotoxicity.
    Chen R; Zhou M; Zhu F
    J Cardiovasc Dev Dis; 2022 Nov; 9(11):. PubMed ID: 36354777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management.
    Zhou YW; Zhu YJ; Wang MN; Xie Y; Chen CY; Zhang T; Xia F; Ding ZY; Liu JY
    Front Pharmacol; 2019; 10():1350. PubMed ID: 31849640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
    Waliany S; Lee D; Witteles RM; Neal JW; Nguyen P; Davis MM; Salem JE; Wu SM; Moslehi JJ; Zhu H
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():113-134. PubMed ID: 32776859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can we manage the cardiac toxicity of immune checkpoint inhibitors?
    Poto R; Marone G; Pirozzi F; Galdiero MR; Cuomo A; Formisano L; Bianco R; Della Corte CM; Morgillo F; Napolitano S; Troiani T; Tocchetti CG; Mercurio V; Varricchi G
    Expert Opin Drug Saf; 2021 Jun; 20(6):685-694. PubMed ID: 33749484
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors.
    Torrente M; Blanco M; Franco F; Garitaonaindia Y; Calvo V; Collazo-Lorduy A; Gutiérrez L; Sánchez JC; González-Del-Alba A; Hernández R; Méndez M; Cantos B; Núñez B; Sousa PAC; Provencio M
    Front Cardiovasc Med; 2022; 9():1062858. PubMed ID: 36531707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].
    Liu Y; Chen Y; Zeng Z; Liu A
    Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):668-672. PubMed ID: 34521189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety.
    Rubio-Infante N; Ramírez-Flores YA; Castillo EC; Lozano O; García-Rivas G; Torre-Amione G
    Front Cell Dev Biol; 2022; 10():851032. PubMed ID: 35433707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
    Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.